# Protective Effect ofArtemisia asiatica Extract and Its Active Compound Eupatilin against Cisplatin-Induced Renal Damage

Authors: Jun Yeon Park; Dahae Lee; Hyuk-Jai Jang; Dae Sik Jang; Hak Cheol Kwon; Ki Hyun Kim; Su-Nam Kim; Gwi Seo Hwang; Ki Sung Kang; Dae-Woon Eom
Journal: Evidence-Based Complementary and Alternative Medicine
 (2015)

---

## Abstract

The present study investigated the renoprotective effect of anArtemisia asiatica extract and eupatilin in kidney epithelial (LLC-PK1) cells. Although cisplatin is effective against several cancers, its use is limited due to severe nephrotoxicity. Eupatilin is a flavonoid compound isolated from the Artemisia plant and possesses antioxidant as well as potent anticancer properties. In the LLC-PK1 cellular model, the decline in cell viability induced by oxidative stress, such as that induced by cisplatin, was significantly and dose-dependently inhibited by the A. asiatica extract and eupatilin. The increased protein expressions of phosphorylated JNK and p38 by cisplatin in cells were markedly reduced after A. asiatica extract or eupatilin cotreatment. The elevated expression of cleaved caspase-3 was significantly reduced by A. asiatica extract and eupatilin, and the elevated percentage of apoptotic cells after cisplatin treatment in LLC-PK1 cells was markedly decreased by cotreatment with A. asiatica extract or eupatilin. Taken together, these results suggest that A. asiatica extract and eupatilin could cure or prevent cisplatin-induced renal toxicity without any adverse effect; thus, it can be used in combination with cisplatin to prevent nephrotoxicity.


---

## Body

## 1. Introduction

Cisplatin is a potent chemotherapeutic agent for the treatment of multiple human malignancies [1, 2]. It accumulates in all segments of nephron but is predominantly taken up by the proximal tubule cells, which then provokes severe damage [3]. The efficacy of cisplatin is dose dependent, but the side effect in kidney limits the use of higher doses to improve its chemotherapeutic effects [4, 5]. The toxic effects of cisplatin mainly occur via oxidative stress and DNA damage [6, 7], ultimately leading to apoptotic pathways in tumour cells [8] and also in renal cells [4, 9, 10].For centuries, many natural products have been identified for the prevention and/or treatment of kidney diseases because they are believed to have nephroprotective effects. They are widely used in clinical practice in many parts of the world. For example,Silybum marianum was found to attenuate nephrotoxicity induced by gentamicin in dogs [11]. A water extract ofKalanchoe pinnata leaves protected rat kidneys from gentamicin-induced nephrotoxicity [12]. Salviae Radix extract exerted a protective effect against cisplatin-induced renal cell injury, and its effect might be mediated by its antioxidant effect [13].Artemisia asiatica Nakai is a traditional oriental medicine and it has been used for the treatment of several inflammatory disorders. Recent studies revealed thatA. asiatica has antioxidative and anti-inflammatory effects contributing to its protective effects against various pathophysiological conditions including gastric damage [14], liver damage [15], experimental pancreatitis [16], and tumor promotion [17].Stillen is a commercially available extract fromA. asiatica. Eupatilin (Figure 1(a)), an active compound isolated fromA. asiatica, has been reported to treat peptic ulcers and gastritis. It has antioxidative and anti-inflammatory effects against gastric mucosal injury [18, 19]. Various inflammatory mediators such as cytokines and oxidative stress that can affect gastric mucosal injury are thought to be involved in its action mechanism [20, 21]. Eupatilin was also reported to have therapeutic potential for the treatment of gastric cancer [22, 23].Figure 1
Effects ofA. asiatica extract and eupatilin on cisplatin-induced nephrotoxicity in LLC-PK1 cells. (a) Structure of eupatilin. (b) Comparison of DPPH radical scavenging effects ofA. asiatica extract, eupatilin, and vitamin C. (c) Dose-dependent protective effect ofA. asiatica extract against cisplatin-induced nephrotoxicity in cells. (d) Dose-dependent protective effect of eupatilin against cisplatin-induced nephrotoxicity in cells.
(a)
(b)
(c)
(d)Although cisplatin-induced nephrotoxicity has been well documented, the effects ofA. asiatica and eupatilin on apoptosis in kidney cells after cisplatin exposure remain under active investigation.


## 2. Materials and Methods

### 2.1. Chemicals and Reagents

An ethanolic extract ofA. asiatica and its active compound eupatilin were prepared as reported previously [17, 18]. Cisplatin and 1,1-diphenyl-2-picryl-hydrazyl (DPPH) were purchased from Sigma Chemical Co. (St. Louis, MO, USA). The stock solution of chemicals was prepared in 100% dimethylsulfoxide (DMSO) and stored at −20°C until use. Antibodies for p38, p-p38, JNK, p-JNK, ERK, p-ERK, cleaved caspase-3, and GAPDH were purchased from Cell Signaling (Boston, MA, USA).


### 2.2. Protective Effect against Cisplatin-Induced Nephrotoxicity in Cells

Possible renoprotective effects against cisplatin-induced damage were evaluated in LLC-PK1 cells as reported previously [24]. In brief, LLC-PK1 cells were seeded in 96-well culture plates at 1
×
10
4 cells per well and the test sample and/or radical donor, 25 μM cisplatin, were added to the culture medium. Twenty-four hours later, the cell viability was measured by using a microplate reader (PowerWave XS; Bio-Tek Instruments, Winooski, VT, USA).


### 2.3. DPPH Radical Scavenging Assay

The radical scavenging activity ofA. asiatica and eupatilin against DPPH was determined spectrophotometrically. In microwells, 100 μL of an aqueous solution of the completely dissolved sample (control: 100 μL DW) was added to an ethanolic solution of DPPH (100 μL, 60 μM) according to the reported method [25]. The final concentrations of the tested samples in the assayed solution were 10, 25, 50, and 100 μg/mL. Vitamin C was used as the standard for comparison. The ability to scavenge DPPH radicals was calculated in terms of percentage of inhibition according to the following equation: % i
n
h
i
b
i
t
i
o
n
=
[
(
A
0
-
A
1
)
/
A
0
×
100
], where A
0 is the absorbance of the control (without extract) and A
1 is the absorbance in the presence of the extract.


### 2.4. Western Blot Analysis

Proteins (whole cell extracts, 30μg/lane) were separated by electrophoresis in a precast 4–15% Mini-PROTEAN TGX gel (Bio-Rad, CA, USA) blotted onto PVDF transfer membranes as reported previously [26]. Bound antibodies were visualized using ECL Advance Western Blotting Detection Reagents (GE Healthcare, UK) and a LAS 4000 imaging system (Fujifilm, Japan).


### 2.5. Image-Based Cytometric Assay

To determine the portion of the population that had become apoptotic, cells were stained with annexin V-Alexa Fluor 488 conjugate using a Tali image-based cytometer (Invitrogen, CA, USA) [27]. Propidium iodide (PI) was used to differentiate dead cells (annexin V-positive/PI positive or annexin V-negative/PI positive) from those that were apoptotic (annexin V-positive/PI negative). The percentages of the population reported as viable, apoptotic, and dead by the Tali cytometer were comparable with data from the same samples independently run on a flow cytometer.


### 2.6. Statistical Analysis

Statistical significance was determined through analysis of variance (ANOVA).p values of less than 0.05 were considered statistically significant.


## 2.1. Chemicals and Reagents

An ethanolic extract ofA. asiatica and its active compound eupatilin were prepared as reported previously [17, 18]. Cisplatin and 1,1-diphenyl-2-picryl-hydrazyl (DPPH) were purchased from Sigma Chemical Co. (St. Louis, MO, USA). The stock solution of chemicals was prepared in 100% dimethylsulfoxide (DMSO) and stored at −20°C until use. Antibodies for p38, p-p38, JNK, p-JNK, ERK, p-ERK, cleaved caspase-3, and GAPDH were purchased from Cell Signaling (Boston, MA, USA).


## 2.2. Protective Effect against Cisplatin-Induced Nephrotoxicity in Cells

Possible renoprotective effects against cisplatin-induced damage were evaluated in LLC-PK1 cells as reported previously [24]. In brief, LLC-PK1 cells were seeded in 96-well culture plates at 1
×
10
4 cells per well and the test sample and/or radical donor, 25 μM cisplatin, were added to the culture medium. Twenty-four hours later, the cell viability was measured by using a microplate reader (PowerWave XS; Bio-Tek Instruments, Winooski, VT, USA).


## 2.3. DPPH Radical Scavenging Assay

The radical scavenging activity ofA. asiatica and eupatilin against DPPH was determined spectrophotometrically. In microwells, 100 μL of an aqueous solution of the completely dissolved sample (control: 100 μL DW) was added to an ethanolic solution of DPPH (100 μL, 60 μM) according to the reported method [25]. The final concentrations of the tested samples in the assayed solution were 10, 25, 50, and 100 μg/mL. Vitamin C was used as the standard for comparison. The ability to scavenge DPPH radicals was calculated in terms of percentage of inhibition according to the following equation: % i
n
h
i
b
i
t
i
o
n
=
[
(
A
0
-
A
1
)
/
A
0
×
100
], where A
0 is the absorbance of the control (without extract) and A
1 is the absorbance in the presence of the extract.


## 2.4. Western Blot Analysis

Proteins (whole cell extracts, 30μg/lane) were separated by electrophoresis in a precast 4–15% Mini-PROTEAN TGX gel (Bio-Rad, CA, USA) blotted onto PVDF transfer membranes as reported previously [26]. Bound antibodies were visualized using ECL Advance Western Blotting Detection Reagents (GE Healthcare, UK) and a LAS 4000 imaging system (Fujifilm, Japan).


## 2.5. Image-Based Cytometric Assay

To determine the portion of the population that had become apoptotic, cells were stained with annexin V-Alexa Fluor 488 conjugate using a Tali image-based cytometer (Invitrogen, CA, USA) [27]. Propidium iodide (PI) was used to differentiate dead cells (annexin V-positive/PI positive or annexin V-negative/PI positive) from those that were apoptotic (annexin V-positive/PI negative). The percentages of the population reported as viable, apoptotic, and dead by the Tali cytometer were comparable with data from the same samples independently run on a flow cytometer.


## 2.6. Statistical Analysis

Statistical significance was determined through analysis of variance (ANOVA).p values of less than 0.05 were considered statistically significant.


## 3. Results and Discussion

### 3.1. Effects ofA. asiatica Extract and Eupatilin on Cisplatin-Induced Nephrotoxicity in LLC-PK1 Cells

The antioxidant effects ofA. asiatica and eupatilin were tested using DPPH, a stable free radical. DPPH decolorizes in the presence of antioxidants. The scavenging ability ofA. asiatica and eupatilin was represented by a line diagram and compared with vitamin C (Figure 1(b)). This result suggests that eupatilin is the antioxidant and active component ofA. asiatica. As shown in Figure 1, the cell viability was decreased significantly to about 60% of that of untreated control cells (p
=
0.0004) after 25 μM cisplatin treatment. However, pretreatment with theA. asiatica extract and eupatilin markedly restored cell viability to 80 and 82%, respectively, in a dose-dependent manner (Figures 1(c) and 1(d)).


### 3.2. Involvement of MAPKs-Caspase-3 Signaling Pathway in the Protective Effect ofA. asiatica Extract and Eupatilin against Cytotoxicity in Cultured LLC-PK1 Cells

Figure2 shows the protein expressions of p38, p-p38, JNK, p-JNK, ERK, p-ERK, and cleaved caspase-3 afterA. asiatica (250 μg/mL) and eupatilin (10 and 50 μg/mL) treatment. As shown in Figure 2, the phosphorylation of p38 and JNK was decreased in LLC-PK1 cells byA. asiatica and eupatilin treatments. In addition, the elevated protein expression of cleaved caspase-3 was also markedly reduced byA. asiatica and eupatilin treatments. ERK protein expression in the LLC-PK1 cells was slightly decreased by cisplatin treatment and increased byA. asiatica and eupatilin treatment; however, the differences were not of significant effect.Figure 2
Involvement of the MAPKs-caspase-3 signaling pathway in the protective effect ofA. asiatica extract and eupatilin against cytotoxicity in cultured LLC-PK1 cells. Results of the Western blot show the levels of p-p38, p38, p-JNK, JNK, p-ERK, ERK, and cleaved caspase-3 in LLC-PK1 cells treated withA. asiatica extract and eupatilin and/or cisplatin at different concentrations for 24 h. Whole cell lysates (20 μg) were separated by SDS-PAGE, transferred onto PVDF transfer membranes, and probed with the indicated antibodies. Proteins were visualized using an ECL detection system.


### 3.3. Effects ofA. asiatica Extract and Eupatilin on Apoptosis in LLC-PK1 Cells

Figure3 shows the effects of theA. asiatica extract and eupatilin on apoptosis in LLC-PK1 cells. As shown in Figure 3(a), the number of dead and apoptotic cells, which were stained with red or green colors, was increased by cisplatin treatment, whereas it was decreased after cotreatment with theA. asiatica extract (p
=
0.008) and more significantly eupatilin (p
=
0.003). The elevated percentage of apoptotic cells after cisplatin treatment was markedly decreased after cotreatment with theA. asiatica extract and eupatilin (Figure 3(b)).Figure 3
Effects ofA. asiatica extract and eupatilin on apoptosis in LLC-PK1 cells. (a) Representative images of apoptosis detection. (b) Percentage of annexin V-positive-stained apoptotic cells. Dead and apoptotic cells were stained red and green, respectively. Apoptosis was determined by a Tali image-based cytometer.
(a)
(b)


## 3.1. Effects ofA. asiatica Extract and Eupatilin on Cisplatin-Induced Nephrotoxicity in LLC-PK1 Cells

The antioxidant effects ofA. asiatica and eupatilin were tested using DPPH, a stable free radical. DPPH decolorizes in the presence of antioxidants. The scavenging ability ofA. asiatica and eupatilin was represented by a line diagram and compared with vitamin C (Figure 1(b)). This result suggests that eupatilin is the antioxidant and active component ofA. asiatica. As shown in Figure 1, the cell viability was decreased significantly to about 60% of that of untreated control cells (p
=
0.0004) after 25 μM cisplatin treatment. However, pretreatment with theA. asiatica extract and eupatilin markedly restored cell viability to 80 and 82%, respectively, in a dose-dependent manner (Figures 1(c) and 1(d)).


## 3.2. Involvement of MAPKs-Caspase-3 Signaling Pathway in the Protective Effect ofA. asiatica Extract and Eupatilin against Cytotoxicity in Cultured LLC-PK1 Cells

Figure2 shows the protein expressions of p38, p-p38, JNK, p-JNK, ERK, p-ERK, and cleaved caspase-3 afterA. asiatica (250 μg/mL) and eupatilin (10 and 50 μg/mL) treatment. As shown in Figure 2, the phosphorylation of p38 and JNK was decreased in LLC-PK1 cells byA. asiatica and eupatilin treatments. In addition, the elevated protein expression of cleaved caspase-3 was also markedly reduced byA. asiatica and eupatilin treatments. ERK protein expression in the LLC-PK1 cells was slightly decreased by cisplatin treatment and increased byA. asiatica and eupatilin treatment; however, the differences were not of significant effect.Figure 2
Involvement of the MAPKs-caspase-3 signaling pathway in the protective effect ofA. asiatica extract and eupatilin against cytotoxicity in cultured LLC-PK1 cells. Results of the Western blot show the levels of p-p38, p38, p-JNK, JNK, p-ERK, ERK, and cleaved caspase-3 in LLC-PK1 cells treated withA. asiatica extract and eupatilin and/or cisplatin at different concentrations for 24 h. Whole cell lysates (20 μg) were separated by SDS-PAGE, transferred onto PVDF transfer membranes, and probed with the indicated antibodies. Proteins were visualized using an ECL detection system.


## 3.3. Effects ofA. asiatica Extract and Eupatilin on Apoptosis in LLC-PK1 Cells

Figure3 shows the effects of theA. asiatica extract and eupatilin on apoptosis in LLC-PK1 cells. As shown in Figure 3(a), the number of dead and apoptotic cells, which were stained with red or green colors, was increased by cisplatin treatment, whereas it was decreased after cotreatment with theA. asiatica extract (p
=
0.008) and more significantly eupatilin (p
=
0.003). The elevated percentage of apoptotic cells after cisplatin treatment was markedly decreased after cotreatment with theA. asiatica extract and eupatilin (Figure 3(b)).Figure 3
Effects ofA. asiatica extract and eupatilin on apoptosis in LLC-PK1 cells. (a) Representative images of apoptosis detection. (b) Percentage of annexin V-positive-stained apoptotic cells. Dead and apoptotic cells were stained red and green, respectively. Apoptosis was determined by a Tali image-based cytometer.
(a)
(b)


## 4. Discussion

The protective effect of theA. asiatica extract and eupatilin against cisplatin-induced nephrotoxicity was tested using LLC-PK1 cells, which are the most vulnerable renal tubular cells to oxidative stress [24, 28]. It is reported that reactive oxygen species (ROS) play vital biological roles in cellular homeostasis whereas the increased ROS levels are associated with apoptosis in cells [29–31]. Our result suggests that eupatilin is the antioxidant and active component ofA. asiatica. In addition, pretreatment with theA. asiatica extract and eupatilin markedly ameliorated reduced LLC-PK1 cell viability by cisplatin in a dose-dependent manner.It has been reported that ROS act as a second messenger initiating signal transduction cascades, including the MAPKs signaling pathway [32, 33]. The MAPKs are important mediators for apoptosis induction in response to anticancer drugs, in particular cisplatin [34, 35]. In the present study, the increased protein expressions of phosphorylated JNK and p38 by cisplatin in LLC-PK1 cells were markedly ameliorated afterA. asiatica extract or eupatilin cotreatment. To further investigate the ability ofA. asiatica and eupatilin to prevent apoptosis, we measured the expression levels of cleaved caspase-3, known as an index of apoptosis, in the kidney. As shown in the results,A. asiatica and eupatilin significantly reduced the expression of cleaved caspase-3. These results suggest that cisplatin-induced increases in the ROS level activate MAPKs in LLC-PK1 cells, whereas theA. asiatica extract and eupatilin inhibit the activation of p38 and JNK.Cisplatin-induced renal cell damage is dependent on apoptosis induced by DNA damage [36, 37]. Apoptosis in renal tubular cells has been observed in several kinds of renal disorders [38]. The elevated protein level of cleaved caspase-3 decreased after treatment withA. asiatica extract and eupatilin.In conclusion, our results suggest that theA. asiatica extract can ameliorate nephrotoxicity in LLC-PK1 cells. Eupatilin serves as one of the major components by blocking the MAPKs-caspase-3 signaling cascade.



---

*Source: 483980-2015-10-11.xml*